GLP-1 drugs may reduce alcohol cravings, new study suggests

4 sourcesFirst reported 3 days agoUpdated 3 days ago

Story Compare

Untold

No left-leaning outlet covered this story. You are only seeing one side of the political spectrum.

Center 25%

Right 75%

1 center3 right-leaning

No left-leaning outlets covered this story. Coverage comes exclusively from centrist or right-leaning sources. Left-leaning media may consider the story insignificant, or the story challenges progressive narratives. Seek out left-leaning commentary to complete the picture.

What all sources covered

Research in Greece suggests that GLP-1 medications, typically used for obesity and type 2 diabetes, may reduce alcohol cravings.
The studies indicate a potential link between these medications and decreased desire for alcohol consumption.
This new area of investigation into the effects of GLP-1 drugs opens possibilities for addressing addiction behaviors.
The findings are part of a broader exploration of how these medications impact various dependencies beyond their intended medical uses.
Multiple Greek news outlets have reported on this emerging research and its implications for addiction treatment.

4 sources

Who reported first

NaftemporikiFirst

Proto Thema+22m

newsit.gr+27m

iefimerida.gr+1h

All coverage